Dora Ferrari
Impact in
- Hepatology top 5%
- Liver physiology and pathology
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Lung Cancer Treatments and Mutations
Papers in
- Surgery 3
- Vascular Malformations and Hemangiomas 2
- Co-authors
- Edward G. Garmey (2 shared papers)Brian Schwartz (3 shared papers)Lecia V. Sequist (1 shared paper)Susan Arthur (1 shared paper)Joachim von Pawel (1 shared paper)Wallace Akerley (1 shared paper)David E. Gerber (1 shared paper)Joan H. Schiller (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Blood (1 paper)Cancer (1 paper)Scientific Reports (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesGermanyPoland
In The Last Decade
Dora Ferrari
8 papers receiving 462 citations
Dora Ferrari's Hit Papers
Peers
Comparison fields: 5 of 46
- Hepatology 129
- Pulmonary and Respiratory Medicine 232
- Oncology 164
- Pathology and Forensic Medicine 70
- Cancer Research 44
Countries citing papers authored by Dora Ferrari
This map shows the geographic impact of Dora Ferrari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dora Ferrari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dora Ferrari more than expected).
Fields of papers citing papers by Dora Ferrari
This network shows the impact of papers produced by Dora Ferrari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dora Ferrari. The network helps show where Dora Ferrari may publish in the future.
Co-authors
The 25 scholars most cited alongside Dora Ferrari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung Cancer Hit paper breakdown → | 2011 | 324 |
| 2 | 2012 | 72 | |
| 3 | 2015 | 45 | |
| 4 | 2017 | 20 | |
| 5 | 2012 | 4 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 2 |
About Dora Ferrari
Dora Ferrari is a scholar working on Surgery, Molecular Biology, Genetics, Pathology and Forensic Medicine and Neurology, having authored 8 papers that have together received 472 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (2 papers), Lung Cancer Treatments and Mutations (2 papers), Vascular Malformations and Hemangiomas (2 papers), Lymphoma Diagnosis and Treatment (2 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), Platelet Disorders and Treatments (2 papers), Lung Cancer Research Studies (1 paper) and Urologic and reproductive health conditions (1 paper). The work is most often cited by research in Hepatology (129 citations), Pulmonary and Respiratory Medicine (232 citations), Oncology (164 citations), Pathology and Forensic Medicine (70 citations) and Cancer Research (44 citations). Dora Ferrari has collaborated with scholars based in United States, Germany and Poland. Frequent co-authors include Edward G. Garmey, Brian Schwartz, Lecia V. Sequist, Susan Arthur, Joachim von Pawel, Wallace Akerley, David E. Gerber, Joan H. Schiller, С. В. Орлов and Rodryg Ramlau. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer, Scientific Reports and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.